Exclusive: OpenAI has acquired Orchestra Bio
This story is from 2026-10-20. It is preserved in the archive; the latest stories are on the live feed.
OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios. Why it matters: Rival AI giants OpenAI and Anthropic are both pushing into science as they look to expand beyond their core comp…
Read the full story at Axios AI+ ↗
Timeline · 1 report
- 2026-10-20 17:55 · Axios AI+
Exclusive: OpenAI has acquired Orchestra Bio